Follow
( Publications: 23 | Followers: 0 )

Keynote Lecture: New Combinations in Melanoma: A Role for ...

Refs. Nivolumab (anti-PD-1) 107. 31% (41%) 14%. 41%. 36%. 3.7 mo. 62%. 43%. Sznol ASCO 2013. Topalian NEJM 2012. MK-3475 (anti-PD-1) 117. 38% (52%) 13%. NA. NA >7 mo ...

Publish on Category: All 2

0

Embed

Share

Upload

Keynote Lecture: New Combinations in Melanoma: A Role for ...